Table 2.
Summary of data synthesis.
| Clinical features | OR (95% CI) | P value | Heterogeneity | Pub bias | |
|---|---|---|---|---|---|
| Q test | I 2 (%) | Harbord test | |||
| Age | 1.16 (0.82–1.64) | 0.40 | 0.46 | 0 | 0.154 |
| Sex | 0.84 (0.56–1.26) | 0.40 | 0.63 | 0 | 0.516 |
| Size of primary lesion | 1.18 (0.67–2.09) | 0.57 | 0.04 | 59 | 0.541 |
| Ipsilateral central lymph node metastasis | 1.16 (0.83–1.62) | 0.37 | 0.58 | 0 | 0.490 |
| HT | 1.57 (1.13–2.20) | 0.008 | 0.24 | 28 | 0.333 |
| Multifocality of primary lesion | 3.93 (2.70–5.73) | <0.00001 | 0.87 | 0 | 0.025 |
| Multifocality of contralateral lesion | 1.32 (0.56–3.10) | 0.52 | 0.04 | 68 | 0.220 |
| Capsular invasion | 1.61 (1.10–2.36) | 0.01 | 0.38 | 2 | 0.115 |
This work is licensed under a